Somatostatin Receptor Type 2 (SSTR2) in Bronchopulmonary Carcinoids

被引:0
|
作者
Matteo Fassan
Federico Rea
Roberto Clemente
Giovanna Rizzardi
Marco Pizzi
Luciano Giacomelli
Massimo Rugge
机构
[1] University of Padova,Pathology Unit, Department of Medical Diagnostic Sciences and Special Therapies
[2] University of Padova,Thoracic Surgery Unit, Department of Cardio
[3] Pathology Unit,Thoracic and Vascular Sciences
[4] Istituto Oncologico Veneto IOV-IRCCS,Unit of Surgical Pathology
[5] Azienda Ospedaliera di Padova,undefined
来源
Endocrine Pathology | 2010年 / 21卷
关键词
Bronchopulmonary carcinoids; Atypical carcinoid; Typical carcinoid; Somatostatin receptor; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:204 / 205
页数:1
相关论文
共 50 条
  • [21] Somatostatin receptor type 2 (SSTR2) knockout and antagonist blocked PACAP-induced inhibition of gastric acid secretion in mice
    Piqueras, L
    Tache, Y
    Martinez, V
    GASTROENTEROLOGY, 2003, 124 (04) : A608 - A608
  • [22] THE RAT SSTR2 SOMATOSTATIN RECEPTOR SUBTYPE IS COUPLED TO INHIBITION OF CYCLIC-AMP ACCUMULATION
    STRNAD, J
    EPPLER, CM
    CORBETT, M
    HADCOCK, JR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (03) : 968 - 976
  • [23] Overexpression of the somatostatin type 2 (SSTR2) receptor in gastric (AGS-B) cells inhibits HDC promoter activity.
    Henihan, RDJ
    Zhensheng, Z
    Wang, TC
    GASTROENTEROLOGY, 1997, 112 (04) : A1154 - A1154
  • [24] MULTIPLE GENE TRANSCRIPTS OF THE SOMATOSTATIN RECEPTOR SSTR2 - TISSUE SELECTIVE DISTRIBUTION AND CAMP REGULATION
    PATEL, YC
    GREENWOOD, M
    KENT, G
    PANETTA, R
    SRIKANT, CB
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (01) : 288 - 294
  • [25] Gastric secretory response to a meal and modulation of somatostatin and gastrin immunoreactive cells during fasting and feeding in somatostatin receptor type 2 (SSTR2) knockout mice
    Wang, Lixin
    Piqueras, Laura
    Tache, Yvette
    Martinez, Vicente
    GASTROENTEROLOGY, 2006, 130 (04) : A691 - A691
  • [26] IDENTIFICATION OF A CRITICAL ASPARTATE RESIDUE IN TRANSMEMBRANE DOMAIN 3 NECESSARY FOR THE BINDING OF SOMATOSTATIN TO THE SOMATOSTATIN RECEPTOR SSTR2
    STRNAD, J
    HADCOCK, JR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (03) : 913 - 921
  • [27] Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors
    Kim, Joo Young
    Kim, Jisup
    Kim, Yong-il
    Yang, Dong-Hoon
    Yoo, Changhoon
    Park, In Ja
    Ryoo, Baek-Yeol
    Ryu, Jin-Sook
    Hong, Seung-Mo
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [28] Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in High-Risk Neuroblastoma
    Alexander, N.
    Marrano, P.
    Thorner, P.
    Zhang, L.
    Irwin, M.
    Baruchel, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S192 - S192
  • [29] RETRACTED: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retracted Article)
    Yu, Benxia
    Zhang, Zhongsheng
    Song, Hao
    Chi, Yuchun
    Shi, Chunling
    Xu, Miao
    MEDICAL SCIENCE MONITOR, 2017, 23 : 1947 - 1955
  • [30] SUBTYPE-SPECIFIC SIGNALING MECHANISMS OF SOMATOSTATIN RECEPTORS SSTR1 AND SSTR2
    HOU, CF
    GILBERT, RL
    BARBER, DL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (14) : 10357 - 10362